Twitter Feed

ASCO has released recommendations to streamline serious adverse events reporting for cancer clinical trials.https://t.co/RZZEbw2eJB

Pazdur: “Clinical trials are here to serve patients. Patients are not here to serve clinical trials.” Make it true.

The crowd is gathering for the grand opening ceremony for #UBuffalo’s new Jacobs School of Medicine and Biomedical Sciences building! We will live tweet from today’s event shortly.

Analysis of Drug Development Paradigms for Immune Checkpoint inhibitors. - Fast track is safe and effective https://t.co/geccewzJJC

We’re proud to announce the first-ever independent analysis of global immuno-oncology drug development. #immunotherapy
https://t.co/RRLwP81nmj

#JITC Review: #Biomarkers for immunotherapy in bladder cancer: a moving target https://t.co/8etuwbik01

"Predicting response...to #immunotherapy - and perhaps combination immunotherapy with chemotherapy and radiation therapy – may require a more profound deconvolution of the immunological tumor microenvironment." Read more here: https://t.co/Hxu5slZNjI

New research shows #immunotherapy could play a role in blocking cancer recurrence: https://t.co/XDeLujTdSm